Teleflex Earnings Preview
Teleflex (NYS: TFX) hasn't been able to establish an earnings trend, bouncing between beating and falling short of estimates during the past fiscal year. The company will unveil its latest earnings on Thursday, Feb. 23. Teleflex is a global provider of medical technology products that enable healthcare providers to improve patient outcomes, reduce infections, and enhance patient and provider safety.
What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on Teleflex with five of eight analysts rating it hold. Analysts don't like Teleflex as much as competitor Cooper Companies overall. Five out of eight analysts rate Cooper a buy compared to three of eight for Teleflex. While analysts still rate the stock a hold, they are a little more optimistic about it compared to three months ago.
- Revenue forecasts: On average, analysts predict $404.4 million in revenue this quarter. That would represent a decline of 18% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $1.22 per share. Estimates range from $1.20 to $1.23.
What our community says:
CAPS All-Stars are strongly backing the stock, with 93.3% granting it an "outperform" rating. The greater community backs the All-Stars, as 92.7% give it a rating of "outperform." Even with a robust four out of five stars, Teleflex's CAPS rating falls a little short of the community's upbeat outlook.
Teleflex's profit has risen year over year by an average of 62.4% over the past five quarters. Revenue has fallen for the past three quarters.
We can help you keep tabs on your companies with My Watchlist, our free, personalized service. Add Teleflex now.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.Earnings estimates provided by Zacks.
At the time this article was published
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.